| RS1972664233 |
DNAH9
|
Health Risk |
Likely pathogenic |
— |
| RS1972735240 |
PPP1R13L
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities |
| RS1972742412 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1972767451 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS1972802448 |
INSR
|
Health Risk |
Likely pathogenic |
Leprechaunism syndrome, Leprechaunism syndrome |
| RS1972803770 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1972861647 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS1972867616 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1972879158 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1972879328 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1972905468 |
PARN
|
Health Risk |
Pathogenic |
— |
| RS1972948538 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1972986097 |
PPP1R13L
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities |
| RS1973023048 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973023933 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973070541 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973073001 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973089024 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS1973089176 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1973093514 |
PPP1R13L
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Orofacial cleft |
| RS1973100441 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973102039 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973103431 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973123878 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1973124127 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973128133 |
COL4A4
|
Health Risk |
Pathogenic |
Hematuria, benign familial |
| RS1973129633 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis, Focal segmental glomerulosclerosis |
| RS1973129665 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1973132502 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1973133322 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973140216 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1973142593 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS1973143259 |
MEOX1
|
Health Risk |
Pathogenic |
— |
| RS1973169054 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973171785 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973176439 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973180778 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1973192389 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973192570 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1973203506 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS1973237748 |
CCDC8
|
Health Risk |
Likely pathogenic |
3M syndrome 3, 3M syndrome 3 |
| RS1973238637 |
NPHS1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS1973248576 |
CCDC8
|
Health Risk |
Likely pathogenic |
3M syndrome 3, 3M syndrome 3 |
| RS1973271240 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS1973343538 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973345860 |
BICRA
|
Health Risk |
Pathogenic |
Intellectual disability, Coffin-Siris syndrome 12 |
| RS1973356105 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973360239 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973379457 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973381731 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973387849 |
BICRA
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 12, Coffin-Siris syndrome 12 |
| RS1973422354 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1973430655 |
PHKB
|
Health Risk |
Pathogenic |
— |
| RS1973468140 |
WDR62
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1973531054 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1973532430 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1973546077 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1973640822 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Microcephaly 2 |
| RS1973672109 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973697345 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1973699059 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS1973699766 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1973745205 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973745447 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1973758214 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1973765207 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS1973796030 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS1973878360 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1973992894 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1974009894 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1974046221 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1974104143 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1974129338 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS1974148669 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1974188923 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1974216738 |
FOXC2
|
Health Risk |
Likely pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1974220729 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1974224118 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1974228323 |
FOXC2
|
Health Risk |
Pathogenic |
— |
| RS1974229664 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1974295317 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1974401494 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1974410266 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia of anesthesia, Malignant hyperthermia of anesthesia |
| RS1974465381 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RYR1-related disorder |
| RS1974467952 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1974497223 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1974567691 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS1974586605 |
KIF1C
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1974604610 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS1974668891 |
KIF1C;LOC126862472
|
Health Risk |
Likely pathogenic |
— |
| RS1974690294 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS1974690692 |
KIF1C
|
Health Risk |
Likely pathogenic |
— |
| RS1974751835 |
KIF1C
|
Health Risk |
Likely pathogenic |
— |
| RS1974868088 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS1974906528 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1974957518 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS1975108349 |
KIF1C
|
Health Risk |
Likely pathogenic |
— |
| RS1975138917 |
KIF1C
|
Health Risk |
Likely pathogenic |
— |
| RS1975233179 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1975291440 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |